Cumberland Pharmaceuticals (CPIX) Capital Expenditures (2010 - 2026)
Cumberland Pharmaceuticals' Capital Expenditures was $38,283 in Q2 2026, up 44.5% from $26,486 a year earlier.
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Capital Expenditures (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cumberland Pharmaceuticals' Capital Expenditures was $62,070 through Jun 30, 2026, down 32.4% year-over-year; for FY2025, it was $97,903, up 47.3% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of -7.0% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $66,461 in FY2024 (-76.4%), $281,268 in FY2023 (+175.4%), $102,148 in FY2022 (-1.3%) and $103,532 in FY2021 (-26.5%).
- The Q2 2026 figure marks the highest quarterly Capital Expenditures since Q1 2025.
- Compared with a year earlier, Capital Expenditures was higher in four of the last six quarters, with growth averaging 36.0%.
- The best year-over-year quarter for Capital Expenditures over five years was Q2 2022 (growth of 810.6%); the worst was Q4 2024 (a decline of 95.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Cumberland Pharmaceuticals | 115.67 Mn | 73.83 Mn | - | 38,283.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38,283.00 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | 23,788.00 |
| Jun 30, 2025 | 26,486.00 |
| Mar 31, 2025 | 47,630.00 |
| Dec 31, 2024 | 2,283.00 |
| Sep 30, 2024 | 15,379.00 |
| Jun 30, 2024 | 7,178.00 |
| Mar 31, 2024 | 41,621.00 |
| Dec 31, 2023 | 48,673.00 |
| Sep 30, 2023 | 53,142.00 |
| Jun 30, 2023 | 72,193.00 |
| Mar 31, 2023 | 107,260.00 |
| Dec 31, 2022 | -153,528.00 |
| Sep 30, 2022 | 91,435.00 |
| Jun 30, 2022 | 137,255.00 |
| Mar 31, 2022 | 26,986.00 |
| Dec 31, 2021 | 9,047.00 |
| Sep 30, 2021 | 59,954.00 |
| Jun 30, 2021 | 15,073.00 |
API Access
Cumberland Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CPIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CPIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CPIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();